Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Phase II Elotuzumab Study Demonstrates 33 Months PFS
This article is from
The Cancer Letter
archive.
Vol. 36 No. 7 | July 26, 2013
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
DCPC Advisors Begin Process Of Setting Priorities For Research
June 21, 1991
TCL Archive
NIH Grantees Win Nobel Prizes In Medicine, Chemistry
October 9, 2009
Primary Source
NCCS Networker Volume 2 Issue 4, Fall 1988
September 13, 1988
TCL Archive
Virus Program Report On Scientific Activities
August 8, 1975
TCL Archive
NIH to Hold Meeting On Faculty Design
February 2, 1996
TCL Archive
Bevacizumab Improves PFS In Advanced Kidney Cancer
July 27, 2007
